---
title: "sjÃ¶grenâ€™s syndrome"
alias: sjogren
slug: "sjogrens-syndrome"
date: "2023-08-05"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[connective tissue diseases]]

# SjÃ¶grenâ€™s syndrome

## Definition & epidemiology

- Chronic dysfxn of exocrine glands (eg, salivary/lacrimal) due to lymphoplasmacytic infiltration, extraglandular manifestations common in primary form
- Can be primary or secondary (a/w RA, scleroderma, SLE, PM, hypothyroidism, HIV)
- ~1/1000 prevelance with 9:1 â™€:â™‚ ratio; typically presents between age 40 & 60
- [[Clinical manifestations of sjÃ¶grenâ€™s syndrome|Clinical manifestations]] ó°’–
- [[Diagnostic studies of sjÃ¶grenâ€™s syndrome|Diagnostic studies]] ó°’–

## Classification criteria (â‰¥4 points 96% Se & 95% Sp; Arthritis Rheumatol 2017;69:35)

- 3 points: âŠ• anti-Ro; labial saliv. gland bx w/ lymphocytic sialadenitis & score â‰¥1 foci/4 mm2
- 1 point: abnormal ocular staining score â‰¥5; Schirmerâ€™s test â‰¤5 mm/5 min; unstimulated salivary flow rate of â‰¤0.1 mL/min

## Treatment (Ann Rheum Dis 2020;79:3)

- Ocular: artificial tears, cyclosporine eyedrops, autologous tears
- Oral: sugar-free gum, lemon drops, saliva substitute, hydration, pilocarpine, cevimeline
- Systemic: depends on extraglandular manifest.; NSAIDs, steroids, DMARDs, rituximab
